Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.28)
# 430
Out of 4,981 analysts
91
Total ratings
41.11%
Success rate
25.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.77 | +107.79% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $2.31 | +73.07% | 10 | Sep 3, 2025 | |
| NVAX Novavax | Assumes: Buy | $10 | $8.12 | +23.15% | 1 | Aug 28, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.90 | +455.56% | 6 | Aug 12, 2025 | |
| KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $8.00 | +62.50% | 5 | Jul 10, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.1 → $1.4 | $0.47 | +200.75% | 2 | Jul 8, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $5.5 → $3 | $0.46 | +552.46% | 12 | Jun 27, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.95 | +4.90% | 13 | May 15, 2025 | |
| VSTM Verastem | Maintains: Buy | $10 → $14 | $9.42 | +48.62% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.95 | +102.02% | 1 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $15.37 | +30.17% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $45.73 | -12.53% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.97 | +84.41% | 3 | Mar 26, 2025 |
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.77
Upside: +107.79%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $2.31
Upside: +73.07%
Novavax
Aug 28, 2025
Assumes: Buy
Price Target: $10
Current: $8.12
Upside: +23.15%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.90
Upside: +455.56%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $8.00
Upside: +62.50%
Senseonics Holdings
Jul 8, 2025
Maintains: Buy
Price Target: $1.1 → $1.4
Current: $0.47
Upside: +200.75%
Plus Therapeutics
Jun 27, 2025
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.46
Upside: +552.46%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.95
Upside: +4.90%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $9.42
Upside: +48.62%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.95
Upside: +102.02%
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $15.37
Upside: +30.17%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $45.73
Upside: -12.53%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $5.97
Upside: +84.41%